SLC1A5 and non-small cell lung carcinoma: SLC1A5 was upregulated on all three data sets so we further validated the increase in SLC1A5 in another population and increased the sample size and we found significantly higher levels of SLC1A5 in the plasma EVs of patients with NSCLC (Figure 1K).